Clinical TrialsSearch results
Number of results: 1187
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Randomized phase III trial of erlotinib versus docetaxel for patients with previously treated advanced non-small cell lung cancer
- Previously treated non-small cell lung cancer
- National Hospital Organization Headquarters Center for Support and Education of Clinical Research
- 2009-08-11
Other
- Randomized phase III trial of Docetaxel versus docetaxel plus S-1 for second-line treatment of non-small cell lung cancer (NSCLC)
- Advanced non-small cell lung cancer
- The Japan-multinational Trial Organization
- 2009-03-31
Other
- Randomized Phase III Trial of Conventional Paclitaxel and Carboplatin Versus Dose Dense weekly Paclitaxel and Carboplatin in Patients With Newly Diagnosed Stage II-IV Mullerian Carcinoma (Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer)
- Patients with stageII-IV Mullerian Carcinoma (Ovarian Epithelial,Primary Peritoneal,or Fallopian Tube Cancer)
- Japanese Gynecologic Oncology Group
- 2005-09-15
Other
- Randomized Phase III Trial Comparing surgery-alone to UFT+PSK in Stage II Rectal Cancer
- Rectal cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2009-01-01
Other
- Randomized phase III trial comparing adjuvant oral UFT/LV to 5-FU/l-LV in stage III colorectal cancer (JCOG-0205-MF)
- Stage III colorectal cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-09-12
Other
- Randomized phase III study of TS-1 alone versus TS-1 plus Lentinan(LNT) in advanced or recurrent gastric cancer (AGC)
- Advanced or recurrent gastric cancer (AGC)
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2007-01-20
Other
- Randomized phase III study of FOLFOX plus bevacizumab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer
- metastatic colorectal cancer
- West Japan Oncology Group
- 2008-09-26
Other
- Randomized phase III study of CPT-11 versus Weekly Paclitaxel for unresectable or recurrent gastric cancer refractory to combination chemotherapy with fluoropyrimidine plus platinum.
- unresectable or recurrent gastric cancer refractory to combination chemotherapy with fluoropyrimidine plus platinum
- West Japan Oncology Group
- 2008-07-15
Other
- Randomized Phase III Study of Adjuvant Endocrine-Therapy with or without Chemotherapy for Postmenopausal Breast Cancer Patients who Responded to Neoadjuvant Letrozole
- postmenopausal primary breast cancer
- NEOS executive committee
- 2008-03-20
Other
- Randomized phase III study of 5-FU continuous infusion (5FUci) versus MTX+5-FU sequential therapy (MF) in gastric cancer with peritoneal metastasis (JCOG0106-MF, MF/5FU)
- gastric cancer with peritoneal metastasis
- Japan Clinical Oncology Group(JCOG)
- 2005-09-07